Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer
Nanotheranostics · 2024
DOI: 10.7150/ntno.88849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanotheranostics, 2024. Verfasst von Md Rajdoula Rafe. Beteiligte Einrichtung: Department of Neuroscience, City University of Hong Kong, Kowloon, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Neurodegenerative disorders encompass diseases that involve the degeneration of neurons, particularly those within the central nervous system. These are the most commonly observed disorders among the geriatric population. The treatment or management of this condition presents additional challenges due to therapeutics that may not be as effective as desired. The primary obstacle that often hinders the efficacy of therapy is the existence of a blood-brain barrier (BBB). The BBB serves as a vital safeguard for the brain, effectively obstructing the passage of drugs into the brain cells. Hence, the management of damaging neurodegenerative conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), Cerebrovascular diseases (CVDs), Huntington's disease (HD), and Multiple sclerosis (MS) is currently the primary area of research interest. The innovative utilization of nanoparticles as drug carriers provides renewed optimism in addressing many complicated medical conditions. In this article, I have aimed to gather published information regarding various lipid nanoparticles that can efficiently transport medication to the brain to address neurodegenerative disorders. According to the published literature, liposomes, solid-lipid nanoparticles, nanostructured nanoparticles, microemulsions, and nanoemulsions are potential nanocarriers that can treat neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, City University of Hong Kong, Kowloon, Hong Kong SAR, China.
- Department of Pharmacy, Jagannath University, Dhaka-1100, Bangladesh.
Zitieren
APA
Rafe, M. R. (2024). Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics. https://doi.org/10.7150/ntno.88849
Vancouver
Rafe MR. Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics. 2024. doi:10.7150/ntno.88849
BibTeX
@article{Rafe2024,
author = {Rafe, Md Rajdoula},
title = {Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer},
journal = {Nanotheranostics},
year = {2024},
doi = {10.7150/ntno.88849}
}
EUVIMED